On the basis of our data, chronic inhibition of LIMK2 may alleviate CVOD, and thereby post-RP ED by improving cavernosal fibrosis via normalizing the LIMK2/Cofilin pathway, although the recovery is incomplete. The gene discussed is CFL1; the disease is retinitis pigmentosa 1.